TY - JOUR T1 - Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 486 LP - 488 DO - 10.1136/ard.55.7.486 VL - 55 IS - 7 AU - N M Buchanan AU - E Toubi AU - M A Khamashta AU - F Lima AU - S Kerslake AU - G R Hughes Y1 - 1996/07/01 UR - http://ard.bmj.com/content/55/7/486.abstract N2 - OBJECTIVE: To study maternal and fetal outcome of pregnancy in patients with lupus who were exposed to hydroxychloroquine (HCQ). METHODS: The case records of women (n = 33) exposed to HCQ during their pregnancies (n = 36) and of 53 control patients from a single lupus pregnancy centre were reviewed to determine lupus activity, obstetric experience, and infant outcome. RESULTS: HCQ was not apparently teratogenic. Lupus activity and obstetric outcome in the two groups were similar. CONCLUSION: HCQ continuation is probably safe during pregnancy in patients with lupus, but there is no obvious advantage in commencing treatment. ER -